Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression

Autism Spectrum Disorders and Mastocytosis

(2017) Theoharis C. Theoharides   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Cognitive impairment in nondemented oldest-old: Prevalence and relationship to cardiovascular risk factors

(2011) Carrie B. Peltz et al.   Alzheimers & Dementia

Mild Cognitive Impairment, Dementia, and Their Subtypes in Oldest Old Women

(2011) Kristine Yaffe et al.   ARCHIVES OF NEUROLOGY

Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study

(2011) Emiliano Rodríguez-Sánchez et al.   BMC Neurology

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

(2011) Daniel Zwilling et al.   CELL

Neuro-immune interactions in the dove brain

(2011) Marta Wilhelm   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country

(2011) Fernando Cáceres et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy

(2011) J. C. Carroll et al.   JOURNAL OF NEUROSCIENCE

Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

(2011) Ebrahim Haroon et al.   NEUROPSYCHOPHARMACOLOGY

Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy

(2011) Daniela Silva Moura et al.   PLoS One

Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder

(2011) Julie Godard et al.   PSYCHIATRY RESEARCH

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

(2011) François Piette et al.   Alzheimers Research & Therapy

Histaminergic Mechanisms for Modulation of Memory Systems

(2011) Cristiano André Köhler et al.   NEURAL PLASTICITY

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

(2010) Carle Paul et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mast cell activation and autism

(2010) Theoharis C. Theoharides et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis.

(2010) Shawn M. McClintock et al.   NEUROPSYCHOLOGY

The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women

(2010) M.C. Craig et al.   PSYCHONEUROENDOCRINOLOGY

Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity

(2009) Neil A. Harrison et al.   BIOLOGICAL PSYCHIATRY

Autism, Gut-Blood-Brain Barrier, and Mast Cells

(2008) Theoharis C. Theoharides et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memory Enhancement with Event-Related Stimulation of the Rostral Intralaminar Thalamic Nuclei

(2008) R. G. Mair et al.   JOURNAL OF NEUROSCIENCE

Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis

(2008) Olivier Hermine et al.   PLoS One

Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset

(2008) Fanny Lanternier et al.   PLoS One

Brain mast cells link the immune system to anxiety-like behavior

(2008) K. M. Nautiyal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults

(2007) Anu E. Castaneda et al.   JOURNAL OF AFFECTIVE DISORDERS